TCL Archive Cancer Policy: Coffey Letter Lists Research Initiatives That Justify Increase December 19, 1997
TCL Archive Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents November 15, 2013
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009